Abstract 4286: TGF-β signature is a therapeutic biomarker for combination immunotherapy for hepatocellular carcinoma

2020 ◽  
Author(s):  
Jian Chen ◽  
Xiaoping Su
Keyword(s):  
Hepatocellular Carcinoma ◽  
Combination Immunotherapy

scholarly journals The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma

2021 ◽  
Vol Volume 8 ◽  
pp. 529-543
Author(s):  
Zhimei Zhou ◽  
Liteng Lin ◽  
Yongcheng An ◽  
Meixiao Zhan ◽  
Ye Chen ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Combination Immunotherapy ◽  
Tlr9 Agonist ◽  
Intratumoural Injection

Columns

2020 ◽  
Vol 24 (03) ◽  
pp. 10-21 ◽  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Combination Immunotherapy ◽  
Healthcare Financing ◽  
Game Changer

The following topics are under this section: Combination Immunotherapy for Hepatocellular Carcinoma Sustainability in Healthcare Financing MiRXES – A Game Changer in MicroRNA Applications

scholarly journals Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice

2021 ◽  
Vol Volume 16 ◽  
pp. 3241-3254
Author(s):  
Yandi Tan ◽  
Shiqi Yang ◽  
Yao Ma ◽  
Jinlin Li ◽  
Qian Xie ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Combination Immunotherapy

Multimodality treatment of hepatocellular carcinoma

1998 ◽  
Vol 13 (11-s4) ◽  
pp. S315-S319 ◽  
Author(s):  
ZHAO-YOU TANG ◽  
XIN-DA ZHOU ◽  
ZENG-CHEN MA ◽  
ZHI-QUAN WU ◽  
JIA FAN ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multimodality Treatment

Hepatocellular carcinoma

1982 ◽  
Vol 118 (1) ◽  
pp. 69-70 ◽  
Author(s):  
A. J. Bennett
Keyword(s):  
Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document